Table 4. Treatment regimens for patients with different types of testicular cancer.
| Diagnosis (n) | Mean cycles (n) | Drugs (n) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy | Radiotherapy | Both | None | BP | BEP | EP | NO | ||
| Seminoma | 2.77 ± 0.44 | 1.75 ± 0.48 | 6.58 ± 0.73 | 32.00% | 52.00% | – | 16.00% | ||
| (50) | (18) | (4) | (24) | (4) | (16) | (26) | (8) | ||
| Mixed germ cell tumour | 1.67 ± 0.24 | – | 6.18 ± 1.23 | 27.77% | 55.55% | 05.55% | 11.11% | ||
| (18) | (5) | (11) | (2) | (5) | (10) | (1) | (2) | ||
| Embryonal carcinoma | 3.00 ± 1.00 | – | 8.00 ± 1.62 | 54.54% | 36.36% | – | 09.09% | ||
| (11) | (3) | (7) | (1) | (6) | (4) | (1) | |||
| Teratoma | 2.25 ± 1.25 | – | 6.40 ± 1.44 | 20.00% | 60.00% | 10.00% | 10.00% | ||
| (10) | (4) | (5) | (1) | (2) | (6) | (1) | (1) | ||
| Yolk sac tumour | 1 | 1 | 8.50 ± 4.20 | – | 77.77% | – | 22.22% | ||
| (9) | (1) | (1) | (6) | (1) | (7) | (2) | |||
BP: bleomycin and etoposide; BEP: bleomycin, etoposide and cisplatin; EP: etoposide and cisplatin; NO: no drugs